HeartSciences Inc (HSCS) FinancialsHSCSHeartSciences Inc

Evaluating the bottom line, HeartSciences Inc maintains a gross margin of 63.81%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -139956.67%, while the net margin is -151064.00%. These profitability ratios, combined with a Return on Equity (ROE) of -1854.61%, provide a clear picture of how effectively HSCS converts its operational activities into shareholder value.

In the context of the broader market, HSCS competes directly with industry leaders such as MODD and ARAY. With a market capitalization of $14.07M, it holds a leading position in the sector. When comparing efficiency, HSCS's gross margin of 63.81% stands against MODD's N/A and ARAY's 30.15%. Such benchmarking helps identify whether HeartSciences Inc is trading at a premium or discount relative to its financial performance.

Heart Test Laboratories has shown a gross margin of 59.06% in Q2 2026, but continues to report significant net income losses, with a loss of $2.35 million in Q2 2026 and an EPS of -0.86 for Q4 2026.